Patients‘ beliefs about inhaled corticosteroids (ICS): relationship with adherence

J. Clatworthy, D. Price, R. Parham, D. Ryan, J. Haughney, R. Horne (London, Aberdeen, United Kingdom)

Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases
Session: Social determinants and psychological issues in primary care respiratory diseases
Session type: Oral Presentation
Number: 373
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Clatworthy, D. Price, R. Parham, D. Ryan, J. Haughney, R. Horne (London, Aberdeen, United Kingdom). Patients‘ beliefs about inhaled corticosteroids (ICS): relationship with adherence. Eur Respir J 2008; 32: Suppl. 52, 373

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1072-1074
Year: 2012


The beliefs about medication questionnaire and adherence in users of inhaled corticosteroids
Source: Eur Respir J 2006; 28: Suppl. 50, 572s
Year: 2006

Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication
Source: International Congress 2017 – Inhalers and their use
Year: 2017


Differences in adherence to inhaled steroid medication in COPD
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011

Patterns of adherence to inhaled corticosteroids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

Determinants of adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA)
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007


Poor adherence to inhaled corticosteroids in childhood asthma: Don‘t blame (only) the patient
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Measures to assess adherence to inhaled corticosteroids for asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 294s
Year: 2003

Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010


Barriers to adherence to inhaled corticosteroids in a high adherent population of children with asthma
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012



Low adherence to inhaled corticosteroids/long-acting ß2-agonists and biologic treatment in severe asthmatics
Source: ERJ Open Res, 6 (2) 00017-2020; 10.1183/23120541.00017-2020
Year: 2020



Suboptimal persistence with inhaled corticosteroid (ICS) mono-therapy among children with persistent asthma in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 709s
Year: 2006

The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

First choice in persistent asthma: inhaled corticosteroids (ICS) or ICS + long-acting beta2-agonist (LABA) combination in steroid-naïve patients?
Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids
Year: 2004


Combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) versus similar ICS dose in children and adults with persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 124s
Year: 2005

Is the combination of long-acting β2-agonists (LABA) and inhaled steroids (ICS) superior to higher ICS dose in children and adults with persistent asthma?
Source: Eur Respir J 2005; 26: Suppl. 49, 124s
Year: 2005